← All startups
IgGenix logo

IgGenix

IgGenix is a biotechnology company that directly addresses food and other severe allergies by re-engineering key antibodies involved in the allergic cascade. IgGenix isolates and transforms allergen-specific IgE antibodies into IgG antibodies that are designed to alleviate and possibly prevent the allergic cascade.

San Francisco, CA, USA
Latest roundSeries B
BiotechnologyBiotechnology ResearchClinical TrialsHealth CareLife ScienceMedical

Team0

No team members listed yet.
Join Discord